Fangyu Kan

1.9k citations
21 papers · 1.2k · h-index 14

Impact in

  • Urology top 1%
    • Urinary Bladder and Prostate Research
  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research

Papers in

  • Hematology 12
    • Hematopoietic Stem Cell Transplantation 12
  • Urology 9
    • Urinary Bladder and Prostate Research 9
Co-authors
Mary Eapen (10 shared papers)Steven Siegel (9 shared papers)Karen Noblett (7 shared papers)Jeffrey Mangel (6 shared papers)Craig V. Comiter (6 shared papers)Tomas L. Griebling (6 shared papers)Jason Bennett (4 shared papers)Samuel Zylstra (5 shared papers)
Journals
Blood (7 papers)Biology of Blood and Marrow Transplantation (5 papers)Neurourology and Urodynamics (3 papers)The Journal of Urology (3 papers)Urology (2 papers)
Partner nations
United StatesUnited KingdomCanada

In The Last Decade

Fangyu Kan

20 papers receiving 1.1k citations

Peers

Fangyu Kan
Comparison fields: 5 of 59
  • Urology 424
  • Hematology 648
  • Transplantation 108
  • Rheumatology 413
  • Immunology 283
Replace John H. Barker with:
John H. Barker United States
Bruno Laganà Italy
Ana Benito Spain
Anja Renziehausen Germany
Alexander Kulagin Russia
M. J. Rood Netherlands
Miki Kondo Japan
Maria Debora De Pasquale Italy
Fumiaki Yoshiba Japan
Friederike Koerber Germany
Fangyu Kan relative to John H. Barker United States John H. Barker's profile →
Citations per field
00.5×10×20×32.6×
John H. Barker · 1×
Citations per year

Countries citing papers authored by Fangyu Kan

Since Specialization
Citations

This map shows the geographic impact of Fangyu Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyu Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyu Kan more than expected).

Fields of papers citing papers by Fangyu Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyu Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyu Kan. The network helps show where Fangyu Kan may publish in the future.

Co-authors

The 25 scholars most cited alongside Fangyu Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fangyu Kan Line = papers co-authored together Fangyu Kan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Blood ·Robert J. Soiffer, Jennifer Le‐Rademacher, Vincent T. Ho, Fangyu Kan, Andrew Artz, Richard E. Champlin, Steven M. Devine, Luis Isola, Hillard M. Lazarus, David I. Marks, David Porter, Edmund K. Waller, Mary M. Horowitz, Mary Eapen
2011253
2
Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder
Neurourology and Urodynamics ·Steven Siegel, Karen Noblett, Jeffrey Mangel, Tomas L. Griebling, Suzette E. Sutherland, Erin T. Bird, Craig V. Comiter, Daniel J. Culkin, Jason Bennett, Samuel Zylstra, Kellie Chase Berg, Fangyu Kan, Christopher P. Irwin
2014161
3
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia
Blood ·Andromachi Scaradavou, Claudio G. Brunstein, Mary Eapen, Jennifer Le‐Rademacher, Juliet N. Barker, Nelson J. Chao, Corey Cutler, Colleen Delaney, Fangyu Kan, Luis Isola, Chatchada Karanes, Mary J. Laughlin, John E. Wagner, Elizabeth J. Shpall
2012121
4
Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation
The Journal of Urology ·Steven Siegel, Karen Noblett, Jeffrey Mangel, Jason Bennett, Tomas L. Griebling, Suzette E. Sutherland, Erin T. Bird, Craig V. Comiter, Daniel J. Culkin, Samuel Zylstra, Fangyu Kan, Kellie Chase Berg
2017114
5
Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation
Urology ·Steven Siegel, Karen Noblett, Jeffrey Mangel, Tomas L. Griebling, Suzette E. Sutherland, Erin T. Bird, Craig V. Comiter, Daniel J. Culkin, Jason Bennett, Samuel Zylstra, Fangyu Kan, Elizabeth Thiery
201691
6
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
Blood ·Amin M. Alousi, Jennifer Le‐Rademacher, Rima M. Saliba, Frederick R. Appelbaum, Andrew Artz, Jonathan Benjamin, Steven M. Devine, Fangyu Kan, Mary J. Laughlin, Hillard M. Lazarus, Jane L. Liesveld, Miguel‐Angel Perales, Richard T. Maziarz, Mitchell Sabloff, Edmund K. Waller, Mary Eapen, Richard E. Champlin
201388
7
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
Blood ·Claudio G. Brunstein, Mary Eapen, Kwang Woo Ahn, Frederick R. Appelbaum, Karen K. Ballen, Richard E. Champlin, Corey Cutler, Fangyu Kan, Mary J. Laughlin, Robert J. Soiffer, Daniel J. Weisdorf, Anne Woolfrey, John E. Wagner
201284
8
Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder
Neurourology and Urodynamics ·Karen Noblett, Steven Siegel, Jeffrey Mangel, Tomas L. Griebling, Suzette E. Sutherland, Erin T. Bird, Craig V. Comiter, Daniel J. Culkin, Jason Bennett, Samuel Zylstra, Fangyu Kan, Kellie Chase Berg
201474
9
One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood and Marrow Transplant Research Results in the Era of Molecular HLA Typing
Biology of Blood and Marrow Transplantation ·David Valcárcel, Jorge Sierra, Tao Wang, Fangyu Kan, Vikas Gupta, Gregory A. Hale, David I. Marks, Philip L. McCarthy, Machteld Oudshoorn, Effie W. Petersdorf, Olle Ringdén, Michelle Setterholm, Stephen R. Spellman, Edmund K. Waller, James Gajewski, Susana R. Marino, David Senitzer, Stephanie J. Lee
201039
10
HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation
Blood ·Judith A. Wade, Carolyn Katovich Hurley, Steven K. Takemoto, John S. Thompson, Stella M. Davies, Thomas Fuller, Glenn E. Rodey, Dennis L. Confer, Harriet Noreen, Michael Haagenson, Fangyu Kan, John P. Klein, Mary Eapen, Stephen R. Spellman, Craig Kollman
200731
11
Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies
Biology of Blood and Marrow Transplantation ·Jakob Passweg, Mei-Jie Zhang, Vanderson Rocha, Fangyu Kan, Richard E. Champlin, Luis Isola, Adrian P. Gee, John Gibson, Mary J. Laughlin, Hillard M. Lazarus, Alison W. Loren, David I. Marks, Aloïs Gratwohl, Mary Eapen
201125
12
Rapid Transport and Infusion of Hematopoietic Cells Is Associated with Improved Outcome after Myeloablative Therapy and Unrelated Donor Transplant
Biology of Blood and Marrow Transplantation ·Hillard M. Lazarus, Fangyu Kan, Sergey Tarima, Richard E. Champlin, Dennis L. Confer, Noelle V. Frey, Adrian P. Gee, John E. Wagner, Mary M. Horowitz, Mary Eapen
200922
13
The Effect of the Composition of Unrelated Donor Bone Marrow and Peripheral Blood Progenitor Cell Grafts on Transplantation Outcomes
Biology of Blood and Marrow Transplantation ·Nancy Collins, Adrian P. Gee, April Durett, Fangyu Kan, Mei-Jie Zhang, Richard E. Champlin, Dennis L. Confer, Mary Eapen, Alan Howard, Roberta King, Mary J. Laughlin, Robert Plante, Michelle Setterholm, Stephen R. Spellman, Carolyn A. Keever-Taylor, John E. Wagner, Daniel J. Weisdorf
200920
14
Prospective Randomized Feasibility Study Assessing the Effect of Cyclic Sacral Neuromodulation on Urinary Urge Incontinence in Women
Female Pelvic Medicine & Reconstructive Surgery ·Steven Siegel, Karl J. Kreder, Elizabeth Takacs, Rachael McNamara, Fangyu Kan
201715
15
A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome
Urology ·Kathleen C. Kobashi, Victor W. Νitti, Eric Margolis, Peter K. Sand, Steven Siegel, Salil Khandwala, Diane K. Newman, Scott MacDiarmid, Fangyu Kan, Elizabeth Michaud
201910
16
Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients
Neurourology and Urodynamics ·Karen Noblett, Kellie Chase Berg, Fangyu Kan, Steven Siegel
20186
17
The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation in Hematologic Malignancies Are Not Associated with Patient Age
Biology of Blood and Marrow Transplantation ·Lujia Dong, Tong Wu, Zhi-yong GAO, Mei-Jie Zhang, Fangyu Kan, Stephen R. Spellman, Xi-You Tan, Yan-Li Zhao, Jing-Bo Wang, Dao-Pei Lu, David B. Miklos, Effie W. Petersdorf, Marcelo Fernández-Viña, Stephanie J. Lee
20105
18
Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes
Blood ·Claudio G. Brunstein, Mary Eapen, Kwang Woo Ahn, Frederick R. Appelbaum, Karen K. Ballen, Richard Champlin, Fangyu Kan, Mary J. Laughlin, Robert J. Soiffer, Daniel J. Weisdorf, Ann Woolfrey, Mary M. Horowitz, John E. Wagner
20102
19
MP77-15 QUALITY OF LIFE AFTER SACRAL NEUROMODULATION: DOES IT DIFFER IN SUBJECTS ACROSS DIFFERENT OVERACTIVE BLADDER DIAGNOSES?
The Journal of Urology ·Karen Noblett, Jeffrey Mangel, Craig V. Comiter, Erin T. Bird, Tomas L. Griebling, Suzette E. Sutherland, Kira Q. Stolen, Fangyu Kan, Steven Siegel
20161
20
Impact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignanciesimpact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies
Blood ·Robert J. Soiffer, Jennifer Le‐Rademacher, Vincent T. Ho, Fangyu Kan, Andrew Artz, Richard E. Champlin, Steven M. Devine, Hillard M. Lazarus, David I. Marks, David L. Porter, Edmund K. Waller, Mary M. Horowitz, Mary Eapen
20101

About Fangyu Kan

Fangyu Kan is a scholar working on Hematology, Urology, Rheumatology, Immunology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), Urinary Bladder and Prostate Research (9 papers), Pelvic floor disorders treatments (9 papers), T-cell and B-cell Immunology (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Sexual function and dysfunction studies (3 papers) and Renal Transplantation Outcomes and Treatments (3 papers). The work is most often cited by research in Urology (424 citations), Hematology (648 citations), Transplantation (108 citations), Rheumatology (413 citations) and Immunology (283 citations). Fangyu Kan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mary Eapen, Steven Siegel, Karen Noblett, Jeffrey Mangel, Craig V. Comiter, Tomas L. Griebling, Jason Bennett, Samuel Zylstra, Erin T. Bird and Suzette E. Sutherland. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Neurourology and Urodynamics, The Journal of Urology and Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John H. BarkerBreakdown of academic impact, for papers by Bruno LaganàBreakdown of academic impact, for papers by Ana BenitoBreakdown of academic impact, for papers by Anja RenziehausenBreakdown of academic impact, for papers by Alexander KulaginBreakdown of academic impact, for papers by M. J. RoodBreakdown of academic impact, for papers by Miki KondoBreakdown of academic impact, for papers by Maria Debora De PasqualeBreakdown of academic impact, for papers by Fumiaki YoshibaBreakdown of academic impact, for papers by Friederike Koerber